The Cancer Research UK Stratified Medicine Programme as a model for delivering personalised cancer care.
Maria Antonietta CeroneTara C MillsRowena SharpeDavid McBrideMoira MacDonaldSuzanne MacMahonHood MugalaasiPauline RehalAlessandro RettinoHelen RobertsMark RossDonald Edward WhiteJohn PedenJanette RawlingsStephan N HoSimon HollingsworthSanjay PopatGary M MiddletonPeter JohnsonCharles Swantonnull nullPublished in: British journal of cancer (2023)
Genomic screening is routinely used to guide the treatment of cancer patients in many countries. However, several multi-layered factors make this effort difficult to deliver within a clinically relevant timeframe. Here we share the learnings from the CRUK-funded Stratified Medicine Programme for advanced NSCLC patients, which could be useful to better plan future studies.
Keyphrases
- end stage renal disease
- ejection fraction
- newly diagnosed
- study protocol
- chronic kidney disease
- papillary thyroid
- randomized controlled trial
- squamous cell carcinoma
- gene expression
- current status
- dna methylation
- gold nanoparticles
- patient reported outcomes
- replacement therapy
- young adults
- reduced graphene oxide
- combination therapy
- childhood cancer